2018
DOI: 10.1016/j.ejmech.2017.11.077
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 50 publications
1
14
0
Order By: Relevance
“… 139 As an IKKβ inhibitor, EF24 can block the NFκB-signaling pathway by inhibiting IKKβ phosphorylation, leading to cell-cycle arrest at the G 2 /M phase and apoptosis. 140 The proteasome inhibitor MG132 inhibits tumor growth through downregulation of the NFκB-signaling pathway. 141 , 142 In addition, T901 is a novel selective NFκB inhibitor functioning through binding to the NFκB complex in the cytosol, thus blocking its nuclear translocation and target-gene expression.…”
Section: Prospects Of Nfκb Inhibitorsmentioning
confidence: 99%
“… 139 As an IKKβ inhibitor, EF24 can block the NFκB-signaling pathway by inhibiting IKKβ phosphorylation, leading to cell-cycle arrest at the G 2 /M phase and apoptosis. 140 The proteasome inhibitor MG132 inhibits tumor growth through downregulation of the NFκB-signaling pathway. 141 , 142 In addition, T901 is a novel selective NFκB inhibitor functioning through binding to the NFκB complex in the cytosol, thus blocking its nuclear translocation and target-gene expression.…”
Section: Prospects Of Nfκb Inhibitorsmentioning
confidence: 99%
“…The known 2,6-bis(( E )-2-bromobenzylidene)cyclohexan-1-one 4a [ 23 ], 3,5-bis(( E )-2-bromobenzylidene)tetrahydro-4 H -pyran-4-one 4b [ 24 ], 3,5-bis(( E )-2-bromobenzylidene)piperidin-4-one 4c [ 25 ], and 3,5-bis(( E )-2-bromobenzylidene)-1-methylpiperidin-4-one 4d [ 24 , 25 ] were prepared through aldol condensation between 2-bromobenzaldehyde and the appropriate 6-membered cyclic ketones by replacing sodium hydroxide, used as the basic catalyst in the previous reports [ 23 , 24 , 25 ], with barium hydroxide and methanol for 2 h at room temperature. Starting from 4c , compounds 4e – j were obtained by alkylation with suitable alkyl chlorides heating at 60 °C for 2 h in the presence of K 2 CO 3 in dry acetonitrile (MeCN) ( 4e – i ), or by one-pot reductive amination with 4-oxo-4-phenylbutanal and sodium triacetoxyborohydride [NaBH(AcO 3 ) 3 ] in dry dichloromethane (DCM) ( 4j ) for 2 h at room temperature ( Scheme 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…3,5-Bis(( E )-2-bromobenzyliden)piperidin-4-one 4c [ 25 ] (0.46 mmol, 200 g, 1 eq.) and benzyl bromide (1.38 mmol, 164 µL, 3 eq.)…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations